Reversal of human cellular senescence: roles of the p53 and p16 pathways
Open accessThe DOI matches its Crossref record; 60 of the 61 references it cites were found in a registry or an index.
Abstract
Telomere erosion and subsequent dysfunction limits the proliferation of normal human cells by a process termed replicative senescence. Replicative senescence is thought to suppress tumorigenesis by establishing an essentially irreversible growth arrest that requires activities of the p53 and pRB tumor suppressor proteins. We show that, depending on expression of the pRB regulator p16, replicative senescence is not necessarily irreversible. We used lentiviruses to express specific viral and cellular proteins in senescent human fibroblasts and mammary epithelial cells. Expression of telomerase did not reverse the senescence arrest. However, cells with low levels of p16 at senescence resumed robust growth upon p53 inactivation, and limited growth upon expression of oncogenic RAS. In contrast, cells with high levels of p16 at senescence failed to proliferate upon p53 inactivation or RAS expression, although they re-entered the cell cycle without growth after pRB inactivation. Our results indicate that the senescence response to telomere dysfunction is reversible and is maintained primarily by p53. However, p16 provides a dominant second barrier to the unlimited growth of human cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“p16, an inhibitor of CDK4 and CDK6, is also key in several types of senescence26; p21 is activated early on senescence entry and p16 is activated later, probably to maintain the senescence phenotype27”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [26]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, cells that express low p16 INK4a levels (e.g., SEN(REP) or SEN(XRA) HCA2) senesce in response to severe damage by activating the p53 pathway; when p53 is subsequently inactivated in these cells, they resume proliferation [ 62 ], but do not lose the SASP.”
From Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor (2008) · cites this paper as [62]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This accumulation results in persistent activation of RB family proteins, inhibition of E2F transactivation, and consequent cell-cycle arrest, which, in time, cannot be reversed by subsequent inactivation of RB family proteins or p53 (Beause ´ jour et al., 2003).”
From Cellular Senescence: Defining a Path Forward (2019) · cites this paper as Beausejour et al., 2003
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In senescent cells, however, the CDK2 inhibitor p21 WAF1/Cip1 ( CDKN1A ) and CDK4/6 inhibitor p16 INK4A ( CDKN2A ) accumulate.”
From Cellular Senescence: Defining a Path Forward (2019) · cites this paper as Beausejour et al., 2003
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Cell cycle controlling proteins p16, p21, and p53, normally inhibit cell cycle progression and have been shown to be accumulated in senescent cells [49–51].”
From T cell anergy, exhaustion, senescence, and stemness in the tumor microenvironment (2013) · cites this paper as [51]
Experimental — accuracy not yet measured
23 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
CDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115
Telomeres shorten during ageing of human fibroblasts
Harley, C. B., Futcher, A. B., & Greider, C. W. (1990) · Nature · doi:10.1038/345458a0 · Cited by 5,750
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
Self-citationExtension of Life-Span by Introduction of Telomerase into Normal Human Cells
Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C.-P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S., & Wright, W. E. (1998) · Science · doi:10.1126/science.279.5349.349 · Cited by 4,975
A Third-Generation Lentivirus Vector with a Conditional Packaging System
Dull, T., Zufferey, R., Kelly, M., Mandel, R. J., Nguyen, M., Trono, D., & Naldini, L. (1998) · Journal of Virology · doi:10.1128/jvi.72.11.8463-8471.1998 · Cited by 3,341
Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes
Land, H., Parada, L. F., & Weinberg, R. A. (1983) · Nature · doi:10.1038/304596a0 · Cited by 2,804
Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278
Self-citationSwitching and Signaling at the Telomere
Blackburn, E. H. (2001) · Cell · doi:10.1016/s0092-8674(01)00492-5 · Cited by 2,107
Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells
Paddison, P. J., Caudy, A. A., Bernstein, E., Hannon, G. J., & Conklin, D. S. (2002) · Genes & Development · doi:10.1101/gad.981002 · Cited by 1,552
Cited by
Items 301–400 of 1,003
Cellular senescence and chromatin organisation
Narita, M. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603636 · Cited by 95
Self-citationEarly Vascular Ageing and Cellular Senescence in Chronic Kidney Disease
Dai, L., Qureshi, A. R., Witasp, A., Lindholm, B., & Stenvinkel, P. (2019) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2019.06.015 · Cited by 94
Cellular senescence in cancer: clinical detection and prognostic implications
Domen, A., Deben, C., Verswyvel, J., Flieswasser, T., Prenen, H., Peeters, M., Lardon, F., & Wouters, A. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02555-3 · Cited by 94
Park, H., Kim, C.-H., Jeong, J.-H., Park, M., & Kim, K. S. (2016) · Oncotarget · doi:10.18632/oncotarget.7457 · Cited by 92
Cell senescence: Hypertrophic arrest beyond the restriction point
Blagosklonny, M. V. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20750 · Cited by 93
The Senescence–Stemness Alliance – A Cancer-Hijacked Regeneration Principle
Milanovic, M., Yu, Y., & Schmitt, C. A. (2018) · Trends in Cell Biology · doi:10.1016/j.tcb.2018.09.001 · Cited by 92
The role of senescence in cancer development
Mavrogonatou, E., Pratsinis, H., & Kletsas, D. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.06.018 · Cited by 105
Targeting cellular senescence in cancer and aging: roles of p53 and its isoforms
Beck, J., Turnquist, C., Horikawa, I., & Harris, C. (2020) · Carcinogenesis · doi:10.1093/carcin/bgaa071 · Cited by 92
Metformin suppresses vascular smooth muscle cell senescence by promoting autophagic flux
Tai, S., Sun, J., Zhou, Y., Zhu, Z., He, Y., Chen, M., Yang, H., Xiao, Y., Tu, T., Tang, L., et al. (2021) · Journal of Advanced Research · doi:10.1016/j.jare.2021.12.009 · Cited by 106
Quiescence Entry, Maintenance, and Exit in Adult Stem Cells
Mohammad, K., Dakik, P., Medkour, Y., Mitrofanova, D., & Titorenko, V. I. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092158 · Cited by 91
Liu, S., Liu, S., Wang, X., Zhou, J., Cao, Y., Wang, F., & Duan, E. (2011) · Aging Cell · doi:10.1111/j.1474-9726.2011.00704.x · Cited by 90
Irreversibility of cellular senescence: dual roles of p16INK4a/Rb-pathway in cell cycle control
Takahashi, A., Ohtani, N., & Hara, E. (2007) · Cell Division · doi:10.1186/1747-1028-2-10 · Cited by 91
Alotaibi, M., Sharma, K., Saleh, T., Povirk, L. F., Hendrickson, E. A., & Gewirtz, D. A. (2016) · Radiation Research · doi:10.1667/rr14202.1 · Cited by 90
Regulation of senescence escape by TSP1 and CD47 following chemotherapy treatment
Guillon, J., Petit, C., Moreau, M., Toutain, B., Henry, C., Roché, H., Bonichon-Lamichhane, N., Salmon, J. P., Lemonnier, J., Campone, M., et al. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-1406-7 · Cited by 90
Sasaki, M., Ikeda, H., Sato, Y., & Nakanuma, Y. (2008) · Free Radical Research · doi:10.1080/10715760802244768 · Cited by 90
RelA/p65 functions to maintain cellular senescence by regulating genomic stability and DNA repair
Wang, J., Jacob, N. K., Ladner, K. J., Beg, A., Perko, J. D., Tanner, S. M., Liyanarachchi, S., Fishel, R., & Guttridge, D. C. (2009) · EMBO reports · doi:10.1038/embor.2009.197 · Cited by 89
Kim, K. S., Kim, M., Seu, Y. B., Chung, H. Y., Kim, J. H., & Kim, J. (2007) · Aging Cell · doi:10.1111/j.1474-9726.2007.00315.x · Cited by 89
The redox-senescence axis and its therapeutic targeting
Ngoi, N. Y., Liew, A. Q., Chong, S. J. F., Davids, M. S., Clement, M.-V., & Pervaiz, S. (2021) · Redox Biology · doi:10.1016/j.redox.2021.102032 · Cited by 88
Lee, J., Lee, M., Moon, B., Shim, S. H., Fornace, A. J., & Cha, H. (2009) · Stem Cells · doi:10.1002/stem.121 · Cited by 94
Vascular aging: Molecular mechanisms and potential treatments for vascular rejuvenation
Mistriotis, P., & Andreadis, S. T. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2017.05.006 · Cited by 92
Cellular Senescence: The Trojan Horse in Chronic Lung Diseases
Hamsanathan, S., Alder, J. K., Sellares, J., Rojas, M., Gurkar, A. U., & Mora, A. L. (2019) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2018-0410tr · Cited by 86
Cudré-Mauroux, C., Occhiodoro, T., König, S., Salmon, P., Bernheim, L., & Trono, D. (2003) · Human Gene Therapy · doi:10.1089/104303403322495034 · Cited by 87
Cellular Senescence in the Development and Treatment of Cancer
Saretzki, G. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210789941874 · Cited by 87
Regulation of transcription and chromatin structure by pRB: Here, there and everywhere
Talluri, S., & Dick, F. A. (2012) · Cell Cycle · doi:10.4161/cc.21263 · Cited by 88
p16INK4a as a Second Effector of the Telomere Damage Pathway
Jacobs, J. J. L., & de Lange, T. (2005) · Cell Cycle · doi:10.4161/cc.4.10.2104 · Cited by 87
Cellular Senescence: Mechanisms and Therapeutic Potential
Liao, Z., Yeo, H. L., Wong, S. W., & Zhao, Y. X. (2021) · Biomedicines · doi:10.3390/biomedicines9121769 · Cited by 94
miR-335 Directly Targets Rb1 (pRb/p105) in a Proximal Connection to p53-Dependent Stress Response
Scarola, M., Schoeftner, S., Schneider, C., & Benetti, R. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0141 · Cited by 96
Bonifacio, L. N., & Jarstfer, M. B. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012519 · Cited by 85
Senescence-Associated Pro-inflammatory Cytokines and Tumor Cell Plasticity
Vernot, J. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.00063 · Cited by 86
Zhang, H., Xu, J., Long, Y., Maimaitijiang, A., Su, Z., Li, W., & Li, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252312928 · Cited by 111
Tumor suppression by p53: making cells senescent.
Qian, Y., & Chen, X. (2010) · PubMed · doi:10.14670/hh-25.515 · Cited by 85
Crosstalk between the Rb pathway and AKT signaling forms a quiescence-senescence switch.
Imai, Y., Takahashi, A., Hanyu, A., Hori, S., Sato, S., Naka, K., Hirao, A., Ohtani, N., & Hara, E. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.03.006 · Cited by 84
Contribution of p16INK4a to replicative senescence of human fibroblasts
Brookes, S., Rowe, J., del Arroyo, A. G., BOND, J. A., & Peters, G. G. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.04.035 · Cited by 93
Doxorubicin cardiotoxicity and target cells: a broader perspective
Angelis, A. D., Urbanek, K., Cappetta, D., Piegari, E., Ciuffreda, L. P., Rivellino, A., Russo, R., Esposito, G., Rossi, F., & Berrino, L. (2016) · Cardio-Oncology · doi:10.1186/s40959-016-0012-4 · Cited by 98
Li, P., Gan, Y., Xu, Y., Wang, L., Ouyang, B., Zhang, C., Luo, L., Zhao, C., & Zhou, Q. (2017) · International Journal of Biological Sciences · doi:10.7150/ijbs.16770 · Cited by 85
Local senolysis in aged mice only partially replicates the benefits of systemic senolysis
Farr, J. N., Saul, D., Doolittle, M. L., Kaur, J., Rowsey, J. L., Vos, S. J., Froemming, M. N., Lagnado, A. B., Zhu, Y., Weivoda, M., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci162519 · Cited by 81
“Aging bone contains cells with markers of senescence, which, as noted earlier, is a stress response program activated by cyclin-dependent kinase inhibitors, most notably p16 Ink4a (encoded by Cdkn2a ) and p21 Cip1 (encoded by Cdkn1a ) (18, 19).”
Cellular senescence: Implications for metabolic disease
Schafer, M. J., Miller, J. D., & LeBrasseur, N. K. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.08.047 · Cited by 83
Cyclin-Dependent Kinase 2 in Cellular Senescence and Cancer. A Structural and Functional Review
Volkart, P. A., Bitencourt‐Ferreira, G., Souto, A. A., & de Azevedo, W. F. (2018) · Current Drug Targets · doi:10.2174/1389450120666181204165344 · Cited by 83
Tomé, M., Sepúlveda, J. C., Delgado, M., Andrades, J. A., Campisi, J., González, & Bernad, A. (2014) · Stem Cells · doi:10.1002/stem.1699 · Cited by 83
Self-citationNoncatalytic Function of ERK1/2 Can Promote Raf/MEK/ERK-mediated Growth Arrest Signaling
Hong, S.-K., Yoon, S., Moelling, C., Arthan, D., & Park, J.-I. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.012591 · Cited by 83
Mitochondrial DNA damage induces apoptosis in senescent cells
Laberge, R.-M., Adler, D., DeMaria, M., Mechtouf, N., Teachenor, R., Cardin, G. B., Desprez, P.-Y., Campisi, J., & Rodier, F. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.199 · Cited by 82
Self-citationDioxin-induced Immortalization of Normal Human Keratinocytes and Silencing of p53 and p16INK4a
Ray, S. S., & Swanson, H. I. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402771200 · Cited by 82
Angelis, A. D., Piegari, E., Cappetta, D., Russo, R., Esposito, G., Ciuffreda, L. P., Ferraiolo, F. A. V., Frati, C., Fagnoni, F. F., Berrino, L., et al. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.03.438 · Cited by 83
Consequences of Lamin B1 and Lamin B Receptor Downregulation in Senescence
Lukášová, E., Kovařík, A., & Kozubek, S. (2018) · Cells · doi:10.3390/cells7020011 · Cited by 101
Gut microbial-derived phenylacetylglutamine accelerates host cellular senescence
Yang, H., Wang, T., Qian, C., Wang, H., Yu, D., Shi, M., Fu, M., Liu, X., Pan, M., Rong, X., et al. (2025) · Nature Aging · doi:10.1038/s43587-024-00795-w · Cited by 86
Mirzayans, R., Andrais, B., Hansen, G., & Murray, D. (2012) · Biochemistry Research International · doi:10.1155/2012/951574 · Cited by 81
Senescence As an Anticancer Mechanism
Hornsby, P. J. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.10.3101 · Cited by 90
Short-term gain, long-term pain: the senescence life cycle and cancer
Chan, A. S. L., & Narita, M. (2019) · Genes & Development · doi:10.1101/gad.320937.118 · Cited by 80
Self-citationFaheem, M. M., Seligson, N. D., Ahmad, S. M., Rasool, R. U., Gandhi, S. G., Bhagat, M., & Goswami, A. (2020) · Cell Death Discovery · doi:10.1038/s41420-020-0286-z · Cited by 92
Hematopoietic stem cell senescence and cancer therapy-induced long-term bone marrow injury.
Shao, L., Wang, Y., Chang, J., Luo, Y., Meng, A., & Zhou, D. (2013) · PubMed · doi:10.3978/j.issn.2218-676x.2013.07.03 · Cited by 110
Xu, S., Wu, W., Huang, H., Huang, R., Xie, L., Su, A., Liu, S., Zheng, R., Yuan, Y., Zheng, H., et al. (2019) · Aging Cell · doi:10.1111/acel.12918 · Cited by 79
Evidence of sex differences in cellular senescence
Ng, M., & Hazrati, L.-N. (2022) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2022.08.014 · Cited by 78
Bone Marrow-Derived Cells: The Influence of Aging and Cellular Senescence
Beausejour, C. M. (2007) · Springer eBooks · doi:10.1007/978-3-540-68976-8_4 · Cited by 89
Lazorthes, S., Vallot, C., Briois, S., Aguirrebengoa, M., Thuret, J.-Y., Laurent, G. S., Rougeulle, C., Kapranov, P., Mann, C., Trouche, D., et al. (2015) · Nature Communications · doi:10.1038/ncomms6971 · Cited by 78
Doeberitz, M. V. K., Reuschenbach, M., Schmidt, D., & Bergeron, C. (2012) · Expert Review of Proteomics · doi:10.1586/epr.12.13 · Cited by 94
Prognosis, Biology, and Targeting of TP53 Dysregulation in Multiple Myeloma
Flynt, E., Bisht, K. K., Sridharan, V., Ortiz, M., Towfic, F., & Thakurta, A. (2020) · Cells · doi:10.3390/cells9020287 · Cited by 86
Inhibition of VEGF induces cellular senescence in colorectal cancer cells
Hasan, M. R., Ho, S. H. Y., Owen, D. A., & Tai, I. T. (2011) · International Journal of Cancer · doi:10.1002/ijc.26179 · Cited by 78
Majumder, M., House, R. P., Palanisamy, N., Qie, S., Day, T. A., Neskey, D. M., Diehl, J. A., & Palanisamy, V. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1006306 · Cited by 87
The relative contributions of the p53 and pRb pathways in oncogene-induced melanocyte senescence
Haferkamp, S., Tran, S. L., Becker, T. M., Scurr, L. L., Kefford, R. F., & Rizos, H. (2009) · Aging · doi:10.18632/aging.100051 · Cited by 77
Chitikova, Z. V., Gordeev, S. A., Bykova, T. V., Zubova, S. G., Pospelov, V. A., & Pospelova, T. V. (2014) · Cell Cycle · doi:10.4161/cc.28402 · Cited by 77
Immune Aging and Immunotherapy in Cancer
Kaiser, M., Semeraro, M. D., Herrmann, M., Absenger, G., Gerger, A., & Renner, W. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137016 · Cited by 84
Noppe, G., Dekker, P., de Koning‐Treurniet, C., Blom, J., van Heemst, D., Dirks, R. W., Tanke, H. J., Westendorp, R. G. J., & Maier, A. B. (2009) · Cytometry Part A · doi:10.1002/cyto.a.20796 · Cited by 77
Critical requirement for cell cycle inhibitors in sustaining nonproliferative states
Pajalunga, D., Mazzola, A., Salzano, A. M., Biferi, M. G., De Luca, G., & Crescenzi, M. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200608109 · Cited by 77
Dormant cancer cells: programmed quiescence, senescence, or both?
Truskowski, K., Amend, S. R., & Pienta, K. J. (2023) · Cancer and Metastasis Reviews · doi:10.1007/s10555-022-10073-z · Cited by 92
Wang, D., & Jang, D. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1976 · Cited by 82
Di, X. M., Shiu, R. P. C., Newsham, I., & Gewirtz, D. A. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.12.016 · Cited by 84
Probin, V., Wang, Y., Bai, A., & Zhou, D. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.107771 · Cited by 86
Yang, N., & Sen, P. (2018) · Aging · doi:10.18632/aging.101617 · Cited by 75
Autophagy, tissue repair, and fibrosis: a delicate balance
Migneault, F., & Hébert, M. (2021) · Matrix Biology · doi:10.1016/j.matbio.2021.01.003 · Cited by 80
Therapeutic targeting of replicative immortality
Yaswen, P., MacKenzie, K. L., Keith, W. N., Hentosh, P., Rodier, F., Zhu, J., Firestone, G. L., Matheu, A., Carnero, A., Bilsland, A. E., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.03.007 · Cited by 97
Self-citationCellular Senescence and Lung Function during Aging. Yin and Yang
Campisi, J. (2016) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201609-703aw · Cited by 74
Self-citationHuman RAP1 specifically protects telomeres of senescent cells from DNA damage
Lototska, L., Yue, J., Li, J., Giraud-Panis, M.-J. E., Songyang, Z., Royle, N. J., Liti, G., Ye, J., Gilson, É., & Méndez-Bermúdez, A. (2020) · EMBO Reports · doi:10.15252/embr.201949076 · Cited by 76
Wheaton, K., Campuzano, D., Ma, W., Sheinis, M., Ho, B., Brown, G. W., & Benchimol, S. (2017) · Molecular and Cellular Biology · doi:10.1128/mcb.00659-16 · Cited by 73
The thorny path linking cellular senescence to organismal aging
Patil, C. K., Mian, S. I., & Campisi, J. (2005) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2005.08.001 · Cited by 83
Self-citationp53: at the crossroad between cancer and ageing
Papazoglu, C., & Mills, A. (2007) · The Journal of Pathology · doi:10.1002/path.2086 · Cited by 72
Characterization of cellular senescence in doxorubicin-induced aging mice
Sun, T., Zhang, L., Feng, J., Bao, L., Wang, J., Song, Z., Mao, Z., Li, J., & Hu, Z. (2022) · Experimental Gerontology · doi:10.1016/j.exger.2022.111800 · Cited by 73
Cellular Senescence: Mechanisms, Morphology, and Mouse Models
Beck, J. A., Horikawa, I., & Harris, C. C. (2020) · Veterinary Pathology · doi:10.1177/0300985820943841 · Cited by 87
Huang, B., Deo, D., Xia, M., & Vassilev, L. T. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0144 · Cited by 72
Nuclear Accumulation of Globular Actin as a Cellular Senescence Marker
Kwak, I. H., Kim, H. S., Choi, O. R., Ryu, M. S., & Lim, I. K. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1856 · Cited by 72
A functional genetic screen defines the AKT-induced senescence signaling network
Chan, K. T., Blake, S., Zhu, H., Kang, J., Trigos, A. S., Madhamshettiwar, P. B., Diesch, J., Paavolainen, L., Horvath, P., Hannan, R. D., et al. (2020) · Cell Death & Differentiation · doi:10.1038/s41418-019-0384-8 · Cited by 71
Yu, Y.-C., Yang, P.-M., Chuah, Q.-Y., Huang, Y.-H., Peng, C.-W., Lee, Y.-J., & Chiu, S.-J. (2013) · Scientific Reports · doi:10.1038/srep01675 · Cited by 71
Lian, X. J., & Gallouzi, I. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m806372200 · Cited by 83
Corpet, A., Olbrich, T., Gwerder, M., Fink, D., & Stucki, M. (2014) · Cell Cycle · doi:10.4161/cc.26988 · Cited by 71
Biomarkers of Cervical Dysplasia and Carcinoma
Hwang, S., & Shroyer, K. R. (2011) · Journal of Oncology · doi:10.1155/2012/507286 · Cited by 71
Greussing, R., Hackl, M., Charoentong, P., Pauck, A., Monteforte, R., Cavinato, M., Hofer, E., Scheideler, M., Neuhaus, M., Micutkova, L., et al. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-224 · Cited by 70
The Regulation of Cellular Functions by the p53 Protein: Cellular Senescence
Tonnessen-Murray, C. A., Lozano, G., & Jackson, J. G. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026112 · Cited by 70
Neuregulin-1 attenuates stress-induced vascular senescence
Shakeri, H., Gevaert, A. B., Schrijvers, D. M., Meyer, G. R. Y. D., Keulenaer, G. W. D., Guns, P., Lemmens, K., & Segers, V. F. M. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy059 · Cited by 73
Fan, J., An, X., Yang, Y., Xu, H., Fan, L., Deng, L., Li, T., Weng, X., Zhang, J., & Zhao, R. C. (2018) · Aging and Disease · doi:10.14336/ad.2018.1110 · Cited by 76
Role of Senescence and Aging in SARS-CoV-2 Infection and COVID-19 Disease
Lynch, S. M., Guo, G., Gibson, D. S., Bjourson, A. J., & Singh, T. (2021) · Cells · doi:10.3390/cells10123367 · Cited by 77
Targeting senescent cells with NKG2D-CAR T cells
Deng, Y., Kumar, A., Xie, K., Schaaf, K., Scifo, E., Morsy, S., Li, T., Ehninger, A., Bano, D., & Ehninger, D. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-01976-7 · Cited by 75
Premature aging/senescence in cancer cells facing therapy: good or bad?
Calvo, L., Ghadaouia, S., Martinez, A., & Rodier, F. (2015) · Biogerontology · doi:10.1007/s10522-015-9593-9 · Cited by 82
Reuschenbach, M., Waterboer, T., Wallin, K., Einenkel, J., Dillner, J., Hamšíková, E., Eschenbach, D., Zimmer, H., Heilig, B., Kopitz, J., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.23837 · Cited by 70
Parallel pathways in RAF-induced senescence and conditions for its reversion
Jeanblanc, M., Ragu, S., Gey, C., Contrepois, K., Courbeyrette, R., Thuret, J., & Mann, C. (2011) · Oncogene · doi:10.1038/onc.2011.481 · Cited by 79
Karpinets, T. V., & Foy, B. D. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi079 · Cited by 80
Tight Glycemic Control May Increase Regenerative Potential of Myocardium during Acute Infarction
Marfella, R., Sasso, F. C., Cacciapuoti, F., Portoghese, M., Rizzo, M. R., Siniscalchi, M., Carbonara, O., Ferraraccio, F., Torella, M., Petrella, A., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2037 · Cited by 69
Colaianni, G., Errede, M., Sanesi, L., Notarnicola, A., Celi, M., Zerlotin, R., Storlino, G., Pignataro, P., Oranger, A., Pesce, V., et al. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.4192 · Cited by 69
High-order chromatin structure and the epigenome in SAHFs
Chandra, T., & Narita, M. (2013) · Nucleus · doi:10.4161/nucl.23189 · Cited by 69
Self-citationZhang, X., Li, J., Sejas, D. P., & Pang, Q. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502262200 · Cited by 69
Li, H., Wang, Y., Pazhanisamy, S. K., Shao, L., Batinic-Haberle, I., Meng, A., & Zhou, D. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.04.016 · Cited by 68
Disappearance of the Telomere Dysfunction-Induced Stress Response in Fully Senescent Cells
Bakkenist, C. J., Drissi, R., Wu, J., Kastan, M. B., & Dome, J. S. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0453 · Cited by 68
Metadata
- Authors
- Beauséjour, C. M., Krtolica, A., Galimi, F., Narita, M., Lowe, S. W., Yaswen, P., & Campisi, J.
- Affiliations
- Lawrence Berkeley National Laboratory (US)
- Salk Institute for Biological Studies (US)
- Cold Spring Harbor Laboratory (US)
- Buck Institute for Research on Aging (US)
- Corresponding author
- Campisi, Judith
- Venue
- The EMBO Journal
- Published
- 2003-08-15
- Volume
- 22
- Issue
- 16
- Pages
- 4212-4222
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- PMC
- PMC175806
- OpenAlex
- W2061619522
- Cited by
- 1,457
- References
- 61
- Citations by year
- 2026: 46 · 2025: 58 · 2024: 87 · 2023: 94 · 2022: 77 · 2021: 107 · 2020: 77 · 2019: 77 · 2018: 78 · 2017: 63 · 2016: 74 · 2015: 55 · 2014: 59 · 2013: 54 · 2012: 69
- FWCI
- 21.27
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- The EMBO Journal (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (acceptedVersion)
- UnissResearch (Università degli Studi di Sassari) (submittedVersion)
- Funders
- Uehara Memorial Foundation
- National Institute on Aging (R56AG009909, R56AG016379, AG-09909, AG-16379, R01AG016379, R37AG009909)
- National Cancer Institute (P30CA008748)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- cellular senescence, replicative senescence, p53, p16, retinoblastoma protein, telomere dysfunction, telomerase, oncogenic Ras, growth arrest, senescence reversal, mammary epithelial cells, fibroblasts, tumor suppression
- MeSH terms
- Breast, Cell Line, Epithelial Cells, Fibroblasts, Humans, Luminescent Proteins, Models, Biological, Genes, ras, Signal Transduction, Tumor Suppressor Protein p53, Lentivirus Infections, Cellular Senescence, Telomerase, Cyclin-Dependent Kinase Inhibitor p16, Green Fluorescent Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.